home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

28.74 -1.04 (-3.49%)

Official Closing Price Updated: 7:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

32 33 Next >

Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims

March 21, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill ↗

March 17, 2022

Via Benzinga

Hopes For A Peace Accord ↗

March 14, 2022

The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant.

Via Talk Markets

Rhode Island's Opioid Trial Against Teva Begins Today: Reuters ↗

March 14, 2022

The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) alleged responsibility for the opioid crisis begins jury...

Via Benzinga

Why Are Teva Pharmaceutical Shares Trading Higher Today? ↗

February 09, 2022

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)

Via Benzinga

The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical ↗

February 09, 2022

Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.

Via Investor's Business Daily

Earnings Scheduled For February 9, 2022 ↗

February 09, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.

Via Benzinga

7 Drug Stocks to Consider After the Viatris Plunge ↗

March 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

March 04, 2022

On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Price To Earnings Ratio Insights For Teva Pharmaceutical ↗

February 07, 2022

Via Benzinga

Teva, Texas Enter $225M Opioid Settlement Agreement ↗

February 07, 2022

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a

Via Benzinga

Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters ↗

February 28, 2022

Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has agreed to pay $264 million to resolve a class-action lawsuit alleging it engaged in a scheme to delay...

Via Benzinga

Putin on the brink ↗

February 28, 2022

For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.

Via Talk Markets

Red Ink ↗

February 24, 2022

There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph

Via Talk Markets

A Receding tide ↗

February 23, 2022

Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.

Via Talk Markets

Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally

February 24, 2022

Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...

Via FinancialNewsMedia

World Markets News For Thursday ↗

February 17, 2022

Ericsson stock lost another 5.27% today in US markets.

Via Talk Markets

Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora ↗

February 17, 2022

According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...

Via Benzinga

Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment ↗

February 16, 2022

A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O...

Via Benzinga

World Markets News For Monday ↗

February 14, 2022

European markets were down over fear of Ukrainian battles.

Via Talk Markets

Nuclear Winter ↗

February 11, 2022

Mexico is raising interest rates to 6%, from 5.5%.

Via Talk Markets

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

Dampening Exuberance ↗

February 09, 2022

The bond sell-off halted today but the Fed's plans mean this will resume.

Via Talk Markets

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗

February 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Teva Pharmaceutical: Q4 Earnings Insights ↗

February 09, 2022

Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Teva Reports Fourth Quarter and Full Year 2021 Financial Results

February 09, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Markets News for Tuesday ↗

February 08, 2022

Oil stocks are up on huge gains.

Via Talk Markets

Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims

February 07, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Weakened Tech Stocks ↗

February 03, 2022

There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.

Via Talk Markets

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com